600873 梅花生物
已收盘 09-18 15:00:00
资讯
新帖
简况
中邮证券：给予梅花生物买入评级
证券之星 · 09-05
中邮证券：给予梅花生物买入评级
每周股票复盘：8月27日梅花生物（600873）发生2笔大宗交易
证券之星 · 08-30
每周股票复盘：8月27日梅花生物（600873）发生2笔大宗交易
利润大幅滑坡梅花生物遭遇周期大考
新浪证券 · 08-21
利润大幅滑坡梅花生物遭遇周期大考
股市必读：梅花生物中报 - 第二季度单季净利润同比下降27.40%
证券之星 · 08-17
股市必读：梅花生物中报 - 第二季度单季净利润同比下降27.40%
梅花生物（600873）2026年中报简析：净利润同比下降62.56%
证券之星 · 08-16
梅花生物（600873）2026年中报简析：净利润同比下降62.56%
每周股票复盘：梅花生物（600873）Q2净利降27.4%但营收转增
证券之星 · 08-16
每周股票复盘：梅花生物（600873）Q2净利降27.4%但营收转增
梅花生物(600873)6月30日股东户数8.13万户，较上期增加3.59%
证券之星 · 08-15
梅花生物(600873)6月30日股东户数8.13万户，较上期增加3.59%
图解梅花生物中报：第二季度单季净利润同比下降27.40%
证券之星 · 08-15
图解梅花生物中报：第二季度单季净利润同比下降27.40%
梅花生物半年报：净利润同比下滑62.6%
投资观察 · 08-14
梅花生物半年报：净利润同比下滑62.6%
梅花生物董秘刘现芳荣获第十二届金麒麟·金牌董秘荣誉
新浪财经 · 08-10
梅花生物董秘刘现芳荣获第十二届金麒麟·金牌董秘荣誉
每周股票复盘：梅花生物（600873）每股派息0.4285元
证券之星 · 07-19
每周股票复盘：梅花生物（600873）每股派息0.4285元
梅花生物（600873）披露2025年度差异化分红事项法律意见书，7月15日股价上涨3.23%
证券之星 · 07-15
梅花生物（600873）披露2025年度差异化分红事项法律意见书，7月15日股价上涨3.23%
股市必读：梅花生物（600873）预计2026年1-6月扣非后净利润盈利4.3亿元至6.3亿元
证券之星 · 07-13
股市必读：梅花生物（600873）预计2026年1-6月扣非后净利润盈利4.3亿元至6.3亿元
每周股票复盘：梅花生物（600873）上半年净利预降55%-66%
证券之星 · 07-12
每周股票复盘：梅花生物（600873）上半年净利预降55%-66%
梅花生物（600873）披露2026年半年度业绩预告，7月10日股价下跌0.86%
证券之星 · 07-10
梅花生物（600873）披露2026年半年度业绩预告，7月10日股价下跌0.86%
梅花生物(600873.SH)发预减，预计半年度归母净利润6亿元到8亿元，同比减少55%到66%
智通财经 · 07-10
梅花生物(600873.SH)发预减，预计半年度归母净利润6亿元到8亿元，同比减少55%到66%
梅花生物（600873）披露调整2025年年度利润分配方案每股分配比例的公告，7月8日股价上涨0.49%
证券之星 · 07-08
梅花生物（600873）披露调整2025年年度利润分配方案每股分配比例的公告，7月8日股价上涨0.49%
梅花生物：第二季度主产品价格较第一季度环比均有不同程度提升
证券之星 · 07-02
梅花生物：第二季度主产品价格较第一季度环比均有不同程度提升
梅花生物：截止2026年3月31日股东户数为78,445户
证券之星 · 07-02
梅花生物：截止2026年3月31日股东户数为78,445户
梅花生物：其他流动资产增加主要因待抵扣税金及短期理财增加
证券之星 · 07-02
梅花生物：其他流动资产增加主要因待抵扣税金及短期理财增加
加载更多
公司概况
公司名称：
梅花生物科技集团股份有限公司
所属行业：
食品制造业
上市日期：
1995-02-17
主营业务：
梅花生物科技集团股份有限公司的主营业务是氨基酸的规模化生产。公司的主要产品是动物营养氨基酸类产品、食品味觉性状优化产品、人类营养与医用氨基酸类产品、石油级黄原胶、生物有机肥。
发行价格：
3.50
{"stockData":{"symbol":"600873","market":"SH","secType":"STK","nameCN":"梅花生物","latestPrice":7.53,"timestamp":1789714801000,"preClose":7.51,"halted":0,"volume":14737280,"delay":0,"changeRate":0.0027,"floatShares":2804000000,"shares":2804000000,"eps":0.7756,"marketStatus":"已收盘","change":0.02,"latestTime":"09-18 15:00:00","open":7.5,"high":7.56,"low":7.46,"amount":111000000,"amplitude":0.0133,"askPrice":7.54,"askSize":376,"bidPrice":7.53,"bidSize":660,"shortable":0,"etf":0,"ttmEps":0.7756,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789954200000},"marketStatusCode":5,"adr":0,"adjPreClose":7.51,"symbolType":"stock","openAndCloseTimeList":[[1789695000000,1789702200000],[1789707600000,1789714800000]],"highLimit":8.26,"lowLimit":6.76,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2804241650,"isCdr":false,"pbRate":1.35,"roa":"--","peRate":9.708613,"roe":"4.03%","epsLYR":1.17,"committee":-0.093335,"marketValue":21116000000,"turnoverRate":0.0053,"status":0,"floatMarketCap":21116000000},"requestUrl":"/m/hq/s/600873","defaultTab":"news","newsList":[{"id":"2665363331","title":"中邮证券：给予梅花生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2665363331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665363331?lang=zh_cn&edition=full","pubTime":"2026-09-05 19:30","pubTimestamp":1788607833,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司刘海荣,李金凤近期对梅花生物进行研究并发布了研究报告《传统周期承压，医药氨基酸与全球化布局打开成长空间》，给予梅花生物买入评级。公司20262028年对应PE估值分别为11倍、8倍、7倍，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级5家，增持评级3家；过去90天内机构目标均价为9.6。本文数据来源于中邮证券有限责任公司，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090500012173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048366","title":"每周股票复盘：8月27日梅花生物（600873）发生2笔大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048366?lang=zh_cn&edition=full","pubTime":"2026-08-30 05:16","pubTimestamp":1788038176,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，梅花生物（600873）报收于7.89元，较上周的7.76元上涨1.68%。本周，梅花生物8月26日盘中最高价报7.95元。8月27日盘中最低价报7.65元。梅花生物当前最新总市值221.25亿元，在化学制品板块市值排名15/171，在两市A股市值排名905/5211。本周关注点交易信息汇总：8月27日梅花生物发生2笔大宗交易，成交金额2642.07万元交易信息汇总8月27日梅花生物发生2笔大宗交易，成交金额2642.07万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0012","BK0070","BK0033","BK0226","600873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661257707","title":"利润大幅滑坡梅花生物遭遇周期大考","url":"https://stock-news.laohu8.com/highlight/detail?id=2661257707","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661257707?lang=zh_cn&edition=full","pubTime":"2026-08-21 14:43","pubTimestamp":1787294580,"startTime":"0","endTime":"0","summary":"作为全球最大氨基酸生产企业，公司营收基本持平，但利润出现上市以来最大幅度的中期回调，周期弱点、财务隐患同步暴露，龙头企业穿越行业低谷的能力受到市场拷问。大宗氨基酸产品价格受供需影响波动剧烈，当行业下行周期到来，公司利润会被快速侵蚀，主业盈利稳定性不足的问题充分显现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-08-21/doc-inipaenp6465812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0226","BK0028","BK0188","BK0033","600873","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660170806","title":"股市必读：梅花生物中报 - 第二季度单季净利润同比下降27.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660170806","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660170806?lang=zh_cn&edition=full","pubTime":"2026-08-17 01:25","pubTimestamp":1786901109,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告2026年上半年主营收入122.35亿元，同比下降0.37%；归母净利润6.62亿元，同比下降62.56%；扣非净利润4.51亿元，同比下降72.28%；第二季度单季度归母净利润5.44亿元，同比下降27.4%；负债率41.49%，毛利率12.93%，财务费用5359.98万元，投资收益5791.21万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659179320","title":"梅花生物（600873）2026年中报简析：净利润同比下降62.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659179320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659179320?lang=zh_cn&edition=full","pubTime":"2026-08-16 06:02","pubTimestamp":1786831329,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期梅花生物发布2026年中报。根据财报显示，梅花生物净利润同比下降62.56%。截至本报告期末，公司营业总收入122.35亿元，同比下降0.37%，归母净利润6.62亿元，同比下降62.56%。按单季度数据看，第二季度营业总收入62.49亿元，同比上升3.95%，第二季度归母净利润5.44亿元，同比下降27.4%。去年的净利率为13.55%，算上全部成本后，公司产品或服务的附加值高。本文数据来源于梅花生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600001240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659754611","title":"每周股票复盘：梅花生物（600873）Q2净利降27.4%但营收转增","url":"https://stock-news.laohu8.com/highlight/detail?id=2659754611","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659754611?lang=zh_cn&edition=full","pubTime":"2026-08-16 02:00","pubTimestamp":1786816841,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，梅花生物报收于7.95元，较上周的7.88元上涨0.89%。2026年第二季度，单季度主营收入62.49亿元，同比上升3.95%；单季度归母净利润5.44亿元，同比下降27.4%；单季度扣非净利润3.71亿元，同比下降48.73%。营业收入12,235,095,339.54元，同比下降0.37%；利润总额830,402,774.44元，同比下降60.25%；归母净利润661,862,706.23元，同比下降62.56%；扣非净利润451,313,771.78元，同比下降72.28%。梅花生物关于召开2026年半年度业绩说明会的公告公司将于2026年8月26日11:00-12:00通过上证路演中心网络互动方式召开业绩说明会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659789661","title":"梅花生物(600873)6月30日股东户数8.13万户，较上期增加3.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659789661","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659789661?lang=zh_cn&edition=full","pubTime":"2026-08-15 17:02","pubTimestamp":1786784577,"startTime":"0","endTime":"0","summary":"证券之星消息，近日梅花生物披露，截至2026年6月30日公司股东户数为8.13万户，较3月31日增加2818.0户，增幅为3.59%。在化学制品行业个股中，梅花生物股东户数高于行业平均水平，截至6月30日，化学制品行业平均股东户数为2.84万户。从股价来看，2026年3月31日至2026年6月30日，梅花生物区间跌幅为35.81%，在此期间股东户数增加2818.0户，增幅为3.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081500012599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0028","BK0033","600873","BK0012","BK0226","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123275","title":"图解梅花生物中报：第二季度单季净利润同比下降27.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123275","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659123275?lang=zh_cn&edition=full","pubTime":"2026-08-15 01:15","pubTimestamp":1786727728,"startTime":"0","endTime":"0","summary":"证券之星消息，梅花生物2026年中报显示，上半年度公司主营收入122.35亿元，同比下降0.37%；归母净利润6.62亿元，同比下降62.56%；扣非净利润4.51亿元，同比下降72.28%；其中2026年第二季度，公司单季度主营收入62.49亿元，同比上升3.95%；单季度归母净利润5.44亿元，同比下降27.4%；单季度扣非净利润3.71亿元，同比下降48.73%；负债率41.49%，投资收益5791.21万元，财务费用5359.98万元，毛利率12.93%。财报数据概要请见下图:本文数据来源于梅花生物2026年中报，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081500001858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198940370","title":"梅花生物半年报：净利润同比下滑62.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198940370","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198940370?lang=zh_cn&edition=full","pubTime":"2026-08-14 19:19","pubTimestamp":1786706371,"startTime":"0","endTime":"0","summary":"梅花生物科技集团股份有限公司（600873.SS）于8月14日披露了半年度业绩报告。数据显示，公司在今年上半年实现的归属于母公司所有者的净利润，与去年同期相比，大幅下降了62.6%。这一显著的下滑趋势，反映出企业经营正面临阶段性压力。详细财务数据均已在公司公告中完整呈现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0226","BK0012","BK0188","BK0033","600873","BK0070","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658966981","title":"梅花生物董秘刘现芳荣获第十二届金麒麟·金牌董秘荣誉","url":"https://stock-news.laohu8.com/highlight/detail?id=2658966981","media":"新浪财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658966981?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:49","pubTimestamp":1786351740,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索查看更多考评等级专题：专题：第十二届金麒麟·金牌董秘及优秀证代荣誉榜单揭晓！8月10日，新浪财经第十二届金麒麟金牌董秘榜单正式揭晓。梅花生物董事会秘书刘现芳凭借扎实的合规治理能力、成熟的投资者关系运营、长期稳健的资本价值传递表现，荣耀加冕第十二届金麒麟金牌董秘。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-08-10/doc-inimvnpp4914113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0033","BK0012","BK0028","BK0226","600873","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652305982","title":"每周股票复盘：梅花生物（600873）每股派息0.4285元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652305982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652305982?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:26","pubTimestamp":1784399171,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，梅花生物报收于8.53元，较上周的8.06元上涨5.83%。公司公告汇总梅花生物科技集团股份有限公司发布2025年年度权益分派实施公告，每股派发现金红利0.4285元（含税），股权登记日为2026年7月21日，除权（息）日与现金红利发放日均为2026年7月22日。北京市君合律师事务所就梅花生物科技集团股份有限公司2025年度差异化分红事项出具法律意见书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0226","BK0028","BK0188","BK0033","600873","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651406469","title":"梅花生物（600873）披露2025年度差异化分红事项法律意见书，7月15日股价上涨3.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651406469","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651406469?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:06","pubTimestamp":1784124383,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，梅花生物报收于8.62元，较前一交易日上涨3.23%，最新总市值为241.73亿元。该股当日开盘8.3元，最高8.62元，最低8.29元，成交额达2.46亿元，换手率为1.03%。近日，梅花生物科技集团股份有限公司披露北京市君合律师事务所出具的《关于梅花生物科技集团股份有限公司2025年度差异化分红事项的法律意见书》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500044569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0012","600873","BK0226","BK0033","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651165230","title":"股市必读：梅花生物（600873）预计2026年1-6月扣非后净利润盈利4.3亿元至6.3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651165230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651165230?lang=zh_cn&edition=full","pubTime":"2026-07-13 01:16","pubTimestamp":1783876570,"startTime":"0","endTime":"0","summary":"业绩披露要点业绩预告梅花生物预计2026年1-6月归属净利润盈利6亿元至8亿元；扣非后净利润盈利4.3亿元至6.3亿元。公司公告汇总梅花生物2026年半年度业绩预告梅花生物科技集团股份有限公司预计2026年半年度实现归属于母公司所有者的净利润6亿元到8亿元，与上年同期17.68亿元相比减少9.70亿元到11.70亿元，同比减少55%到66%。扣除非经常性损益后的净利润预计为4.30亿元到6.30亿元，同比减少61%到74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300000656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650548631","title":"每周股票复盘：梅花生物（600873）上半年净利预降55%-66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650548631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650548631?lang=zh_cn&edition=full","pubTime":"2026-07-12 01:58","pubTimestamp":1783792691,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，梅花生物报收于8.06元，较上周的7.91元上涨1.9%。本周，梅花生物7月8日盘中最高价报8.29元。本周关注点来自业绩披露要点：梅花生物预计2026年上半年净利同比减少55%到66%。扣非后净利润预计为4.3亿元至6.3亿元，较上年同期分别减少55%至66%和61%至74%。公司公告汇总梅花生物科技集团股份有限公司调整2025年年度利润分配方案每股分配比例，因实施股份回购导致3,999,100股不参与分配。股权登记日将在后续权益分派公告中披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","600873","BK0012","BK0226","BK0028","BK0033","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650413512","title":"梅花生物（600873）披露2026年半年度业绩预告，7月10日股价下跌0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650413512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650413512?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:18","pubTimestamp":1783693106,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，梅花生物报收于8.06元，较前一交易日下跌0.86%，最新总市值为226.02亿元。该股当日开盘8.13元，最高8.19元，最低8.01元，成交额达1.38亿元，换手率为0.61%。近日，梅花生物科技集团股份有限公司披露2026年半年度业绩预告。公告显示，公司预计2026年半年度实现归属于母公司所有者的净利润6亿元到8亿元，与上年同期17.68亿元相比减少9.70亿元到11.70亿元，同比减少55%到66%。本次业绩预告未经注册会计师审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","600873","BK0226","BK0028","BK0012","BK0188","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650189620","title":"梅花生物(600873.SH)发预减，预计半年度归母净利润6亿元到8亿元，同比减少55%到66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650189620","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650189620?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:46","pubTimestamp":1783676772,"startTime":"0","endTime":"0","summary":"智通财经APP讯，梅花生物(600873.SH)发布公告，公司预计2026年半年度实现归属于母公司所有者的净利润6亿元到8亿元，与上年同期17.68亿元相比，预计减少9.70亿元到11.70亿元，同比减少55%到66%。报告期内，受行业供应增加等多重因素影响，公司主要产品味精、苏氨酸、赖氨酸等价格同比下降，导致公司整体经营利润同比下降。公司将持续推进生产与成本管控、加快海外市场及医药氨基酸等高附加值产品布局、深化产能结构与工艺优化升级，不断提升经营韧性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1465970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"梅花生物(600873.SH)发预减，预计半年度归母净利润6亿元到8亿元，同比减少55%到66%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649099464","title":"梅花生物（600873）披露调整2025年年度利润分配方案每股分配比例的公告，7月8日股价上涨0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649099464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649099464?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:26","pubTimestamp":1783520783,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，梅花生物报收于8.13元，较前一交易日上涨0.49%，最新总市值为227.98亿元。该股当日开盘8.07元，最高8.29元，最低8.0元，成交额达1.79亿元，换手率为0.78%。近日，梅花生物科技集团股份有限公司发布关于调整2025年年度利润分配方案每股分配比例的公告。具体股权登记日将在权益分派实施公告中明确。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800042819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0226","BK0188","BK0033","600873","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648037805","title":"梅花生物：第二季度主产品价格较第一季度环比均有不同程度提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2648037805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648037805?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:12","pubTimestamp":1782983526,"startTime":"0","endTime":"0","summary":"证券之星消息，梅花生物(600873)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好 一季度一业绩暴跌主要原因是市场销售价格下降所致。目前市场销售价格情况如何？梅花生物回复：您好，第二季度主产品价格较第一季度环比均有不同程度提升，具体每日产品报价可关注卓创资讯，感谢关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200028360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0226","BK0028","BK0188","BK0033","600873","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648150373","title":"梅花生物：截止2026年3月31日股东户数为78,445户","url":"https://stock-news.laohu8.com/highlight/detail?id=2648150373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648150373?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:09","pubTimestamp":1782983374,"startTime":"0","endTime":"0","summary":"证券之星消息，梅花生物(600873)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问：公司截止2026年6月股东人数是多少 公司股价一直阴跌不止 公司没有想过回购方案梅花生物回复：您好，公司会在定期报告中披露股东户数，截止2026年3月31日股东户数为78,445户，感谢关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200028222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873","BK0226","BK0012","BK0188","BK0028","BK0070","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648503207","title":"梅花生物：其他流动资产增加主要因待抵扣税金及短期理财增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2648503207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648503207?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:09","pubTimestamp":1782983362,"startTime":"0","endTime":"0","summary":"证券之星消息，梅花生物(600873)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，根据梅花今年一季度财报，“其他流动资产”同比上升118.19%、“应收票据”和“存货”同比皆上升50%左右，想问：1、“其他流动资产”大幅度增长原因？2、“应收票据”与“存货”增长原因？是否与扩大投资医用氨基酸有关？梅花生物回复：您好，其他流动资产增加主要因待抵扣税金及短期理财增加，存货增加主要为原材料库存增加，感谢关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200028200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0070","BK0033","600873","BK0226","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789942274122,"stockEarnings":[{"period":"1week","weight":-0.004},{"period":"1month","weight":-0.0284},{"period":"3month","weight":-0.0478},{"period":"6month","weight":-0.3095},{"period":"1year","weight":-0.2605},{"period":"ytd","weight":-0.2188}],"compareEarnings":[{"period":"1week","weight":0.0061},{"period":"1month","weight":0.0045},{"period":"3month","weight":-0.0437},{"period":"6month","weight":-0.0114},{"period":"1year","weight":0.0209},{"period":"ytd","weight":-0.0144}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"梅花生物科技集团股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"81263人(较上一季度增加3.59%)","perCapita":"34508股","listingDate":"1995-02-17","address":"西藏自治区拉萨市堆龙德庆区金珠西路158号阳光新城11幢5号","registeredCapital":"280424万元","survey":" 梅花生物科技集团股份有限公司的主营业务是氨基酸的规模化生产。公司的主要产品是动物营养氨基酸类产品、食品味觉性状优化产品、人类营养与医用氨基酸类产品、石油级黄原胶、生物有机肥。","listedPrice":3.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"梅花生物(600873)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供梅花生物(600873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"梅花生物,600873,梅花生物股票,梅花生物股票老虎,梅花生物股票老虎国际,梅花生物行情,梅花生物股票行情,梅花生物股价,梅花生物股市,梅花生物股票价格,梅花生物股票交易,梅花生物股票购买,梅花生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"梅花生物(600873)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供梅花生物(600873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}